CANOPY Y IMMUNO-THERAPEUTICS
LIVE

Serial Number

79282685

Owner

CANOPY IMMUNO-THERAPEUTICS LTD.

Attorney

Roy D. Gross

Filing Date

Feb 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CANOPY Y IMMUNO-THERAPEUTICS Trademark

Serial Number: 79282685 • Registration: 6513427

CANOPY Y IMMUNO-THERAPEUTICS is a trademark filed by CANOPY IMMUNO-THERAPEUTICS LTD. on February 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CANOPY IMMUNO-THERAPEUTICS LTD. (3 trademarks)

Hagalim 5

Entity Type: 03

Trademark Details

Filing Date

February 13, 2020

Registration Date

October 12, 2021

Published for Opposition

July 27, 2021

Goods & Services

Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases, by eliminating specific lymphocytes' lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes' lineages and attenuate or block antibody creation and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant proteins and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials with potential immunomodulation activity to treat under and over responsiveness of the immune system for the treatment of autoimmune diseases and disorders

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 19, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 18, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 12, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 12, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 15, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 15, 2021 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 27, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jul 24, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 7, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2021 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jun 24, 2021 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 25, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
May 25, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 25, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 25, 2021 EXAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 24, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 24, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 24, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 24, 2021 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2021 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 25, 2020 GNFN
FINAL REFUSAL E-MAILED
Nov 25, 2020 GNFR
FINAL REFUSAL WRITTEN
Nov 25, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2020 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Aug 28, 2020 NREP
REFUSAL PROCESSED BY IB
Jun 12, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
May 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 8, 2020 RFCR
NON-FINAL ACTION WRITTEN
May 7, 2020 CNRT
ASSIGNED TO EXAMINER
May 4, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 14, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 9, 2020 REPR